Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,833,757
-
Share change
-
-655,351
-
Total reported value
-
$21,861,563
-
Put/Call ratio
-
0%
-
Price per share
-
$0.76
-
Number of holders
-
42
-
Value change
-
-$755,904
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q2 2023
As of 30 Jun 2023,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,833,757 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Nantahala Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, CITADEL ADVISORS LLC, Alphabet Inc., VANGUARD GROUP INC, Laurion Capital Management LP, Octagon Capital Advisors LP, RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.